Cargando…
MON-LB114 CGM in Cystic Fibrosis Patients to Predict Cystic Fibrosis-Related Diabetes Onset
Background: Therapeutic progress and improvement on resources enabled the emergence of new comorbidities in cystic fibrosis (CF), such as cystic fibrosis-related diabetes (CFRD). About 20% of adolescents and 40-50% of adults are affected. CFRD and glucose intolerance reduce life expectancy in this p...
Autores principales: | Mei Hsia Pu, Mariana Zorron, Ribeiro, José D, Morcillo, André M, Gonçalves, Aline C, Ribeiro, Antonio F, El Beck, Mayra Souza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209487/ http://dx.doi.org/10.1210/jendso/bvaa046.2126 |
Ejemplares similares
-
SUN-LB026 Do CFTR Modulators Treat Cystic Fibrosis-Related Diabetes?
por: Mehfooz, Ayesha, et al.
Publicado: (2019) -
MON-184 Hypoglycemia During Mixed Meal Tolerance Testing and Early Glucose Dysregulation in Cystic Fibrosis
por: Kilberg, Marissa, et al.
Publicado: (2019) -
SAT-643 Predictors of Technology Success in Cystic Fibrosis Related Diabetes
por: Jain, Ashna, et al.
Publicado: (2020) -
MON-LB122 Psychiatric Medication Induced Diabetes Mellitus
por: Khanal, Bishal, et al.
Publicado: (2020) -
MON-LB024 Episodic Hypoglycemia in Non-Diabetics: Differentiating Distressing from Deadly
por: Windham, Mary, et al.
Publicado: (2019)